Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation
- 1 May 2005
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 25 (9) , 3575-3582
- https://doi.org/10.1128/mcb.25.9.3575-3582.2005
Abstract
Myocyte enhancer factor 2 (MEF2) family proteins are key transcription factors controlling gene expression in myocytes, lymphocytes, and neurons. MEF2 proteins are known to be regulated by phosphorylation. We now provide evidence showing that MEF2C is acetylated by p300 both in vitro and in vivo. In C2C12 myogenic cells, MEF2 is preferentially acetylated in differentiating myocytes but not in undifferentiated myoblasts. Several major acetylation sites are mapped to the transactivation domain of MEF2C, some of which are fully conserved in other MEF2 members from several different species. Mutation of these lysines affects MEF2 DNA binding and transcriptional activity, as well as its synergistic effect with myogenin in myogenic conversion assays. When introduced into C2C12 myoblasts, the nonacetylatable MEF2C inhibits myogenic differentiation. Thus, in addition to phosphorylation, MEF2 activity is also critically regulated by acetylation during myogenesis.Keywords
This publication has 42 references indexed in Scilit:
- Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiationJournal of Cell Science, 2004
- A Novel Complex Regulates cardiac actin Gene Expression through Interaction of Emb, a Class VI POU Domain Protein, MEF2D, and the Histone Transacetylase p300Molecular and Cellular Biology, 2004
- Functional Characterization of an Amino-terminal Region of HDAC4 That Possesses MEF2 Binding and Transcriptional Repressive ActivityJournal of Biological Chemistry, 2003
- Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factorNature Medicine, 2002
- Acetylation of MyoD by p300 Requires More Than Its Histone Acetyltransferase DomainJournal of Biological Chemistry, 2001
- The Insulin-like Growth Factor-Phosphatidylinositol 3-Kinase-Akt Signaling Pathway Regulates Myogenin Expression in Normal Myogenic Cells but Not in Rhabdomyosarcoma-derived RD CellsJournal of Biological Chemistry, 2000
- Neuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2Science, 1999
- A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the proteinThe EMBO Journal, 1998
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997
- Defining the regulatory networks for muscle developmentCurrent Opinion in Genetics & Development, 1996